Our vision “Health for All – Hunger for None” 

Advancing life – that’s what we at Bayer are all about. We put ourselves to the test day in, day out. All together. All over the world. With enthusiasm for new ideas. 

Bayer is a Life Science company with a more than 150-year history of Innovation and core competencies in the areas of health care and agriculture. Thus, we are in the unique position to provide solutions that serve our most basic human needs – health and food. 

Bayer Hellas is the subsidiary of Bayer AG in our country. Our company is operating since 1955, in researching, developing and marketing the locally approved products of Bayer AG, in all the three divisions.   

Find out more about our company in www.bayer.gr  

AbbVie is a global research-driven biopharmaceutical company. We are committed to developing innovative advanced therapies for some of the world’s most complex and serious health issues. AbbVie’s mission is to leverage our experience, dedicated people and unique approach to innovation to significantly improve treatments across five therapeutic areas: Immunology, Hematology, Eye Care, Neuroscience and Aesthetics. More than 47,000 AbbVie employees around the world work daily to develop therapeutic options for patients worldwide.

In Greece, AbbVie since its inception in 2013, has been operating, apart from the commercial branch, an international clinical research hub. The Site Management & Monitoring Operations hub is responsible for a cluster of 14 countries from Europe, Middle East and Africa, and employs more than 40 scientists from different fields. This allows AbbVie to conduct more than 45 clinical studies in our country in a total investment of over 2.5 million € on an annual basis.

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. Please visit  astrazeneca.com  and follow the Company on Twitter @AstraZeneca

Bioiatriki Healthcare Group  is a Greek company, founded in 1981 with the vision to bring equal access to high quality healthcare services for everyone. We are today, the leading privately-owned Primary Healthcare Services provider in Greece, consisting of 56 autonomous Diagnostic Centers in Greece and Cyprus, 2 Clinics in Athens and Thessaloniki, 1 International Patient Center and 7 Dental Clinics.

In our premises we receive more than 3,000,000 patient visits per year. Our success lies in the expertise of our 3,000 highly-qualified employees, 700 of whom are doctors and scientists. Despite current challenges, we continue our expansion with a €45,000,000 multidimensional investment program in technological & medical equipment. Additionally, more than 450.000 people have benefited from our corporate responsibility programs.

Find out more at https://bioiatriki.gr/

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 70,000 employees worldwide. Learn more at iqvia.com

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart

We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.

Learn more at www.janssen.com, www.janssen.com/greece/

Follow us at www.twitter.com/JanssenGlobal, www.linkedin.com/showcase/janssengreece/

Janssen-Cilag Pharmaceutical S.A.C.I. is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Doing now what patients need next

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Learn more at www.roche.gr

Βristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.

Each day, our employees around the world work together for patients – it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through our R&D organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.

For more information visit our website www.bms-greece.gr

PHILIPS: A focused leader in health technology

Philips, with more than 125 years of experience worldwide and more than 90 years of presence in Greece, is at the forefront of medical care.

Guided by deep clinical and consumer insights, Philips delivers innovations and integrated solutions that provide better healthcare outcomes, reduce costs, and improve the working conditions of healthcare professionals.

Our aim is to improve 2.5 billion lives per year by 2030.

Η POTAMITISVEKRIS αποτελεί μία από τις μεγαλύτερες δικηγορικές εταιρείες της Ελλάδος, είναι οργανωμένη στα πρότυπα αντίστοιχων εταιρειών του εξωτερικού, ενώ βασίζεται στον πυλώνα της συμβουλευτικής δικηγορίας και σε αυτόν της δικαστικής επίλυσης. Καλύπτει όλο το φάσμα των νομικών αναγκών μιας επιχείρησης και είναι πιστοποιημένη από την LRQA με το διεθνές πρότυπο ISO 9001. Η εταιρεία είναι ευρέως αναγνωρισμένη και έχει βραβευτεί από τον διεθνή νομικό οδηγό Chambers & Partners, ως «Δικηγορική Εταιρεία της Χρονιάς» για τα έτη 2012, 2014, 2020 & 2021!

About Takeda Pharmaceutical Company

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in healthcare in approximately 80 countries.

For more information: www.takeda.com

Η Π.Ε.Φ. αντιπροσωπεύει τις απόψεις της εγχώριας παραγωγικής φαρμακοβιομηχανίας, έναν τομέα με στρατηγική σημασία για την εθνική οικονομία. Οι φαρμακοβιομηχανίες-μέλη της ΠΕΦ, διατηρούν 29 παραγωγικές μονάδες στην Ελλάδα αναπτύσσοντας και παράγοντας φάρμακα άριστης ποιότητας με τη χρήση τεχνολογίας αιχμής σύμφωνα με τα υψηλά ευρωπαϊκά ποιοτικά πρότυπα GMPs. Οι ελληνικές φαρμακοβιομηχανίες πραγματοποιούν σημαντικές εξαγωγές σε πάνω από 85 χώρες, υλοποιούν προγράμματα σημαντικών επενδύσεων στους τομείς του ποιοτικού ελέγχου και της διασφάλισης της παραγωγικής διαδικασίας, με αποτέλεσμα την ανταγωνιστική παρουσία της στις διεθνείς αγορές με εξαγωγές.

SFEE, The Hellenic Association of Pharmaceutical Companies is one of the most innovative, productive and extravert branches of national economy. It represents more than 90% of the pharmaceutical companies’ active in our country. The 65 member-companies (22 Hellenic and 43 multinational companies), constantly invest in the development of effective medicines and treatments, in order to secure every citizen’s right to health and to a better standard of living. SFEE established in 1982 and for more than 38 years now has championed the common interests of patients, pharmaceutical companies and their workforce.

PhRMA Innovation Forum (PIF) represents 26 leading Research and Development Companies, which work together to meet the medical needs of patients in Greece, to help them have a long, healthy and productive life.

PIF member companies represent 60% of the Greek pharmaceutical market and the majority of domestic investments in international clinical trials with over € 90 million in investments in Greece over the last five years, while employing 3,000 highly trained professionals.

Our common vision is to use our global experience and ensure that patients in Greece have adequate and timely access to the treatment they need.

Our commitment is to work with all relevant sectors in order to contribute to the creation of a fair, democratic, transparent, stable and sustainable health system, which will also reward pharmaceutical innovation.

The Association of Pharmaceutical Products and Jobs Representatives (SAFEE) represents and expresses the views of a large number of Greek representatives and has a strong presence in the medicinal products and para-pharmacies sector.

The Association was established in 2000 to contribute effectively, with targeted proposals/interventions in the Greek pharmaceutical market, towards improving its function and, therefore, strengthening the national economy.